O-2715
| Chemical Compound | |
|---|---|
| Identifiers | |
| CAS Number | |
| PubChem CID | |
| ChemSpider ID | |
| UNII | |
| ChEBI | |
| ChEMBL | |
| Properties | |
| Chemical Formula | |
| Molar Mass | |
| Appearance | |
| Density | |
| Melting Point | |
| Boiling Point | |
| Hazards | |
| GHS Pictograms | [[File:|50px]] |
| GHS Signal Word | |
| GHS Hazard Statements | |
| NFPA 704 | [[File:|50px]] |
| References | |
O-2715 is a synthetic compound that has been studied for its potential effects on the endocannabinoid system. It is classified as a cannabinoid receptor agonist, meaning it binds to and activates cannabinoid receptors in the body. These receptors are part of the endocannabinoid system, which plays a role in regulating various physiological processes such as pain, mood, appetite, and memory.
Chemical Structure and Properties[edit]
O-2715 is a chemical compound with a specific molecular structure that allows it to interact with cannabinoid receptors. The exact chemical structure of O-2715 includes a combination of carbon, hydrogen, nitrogen, and oxygen atoms arranged in a specific configuration. The molecular weight and other physical properties such as melting and boiling points are determined by this structure.
Pharmacology[edit]
O-2715 acts primarily as an agonist at the CB1 receptor and CB2 receptor, which are the two main types of cannabinoid receptors. The CB1 receptor is predominantly found in the central nervous system, while the CB2 receptor is more common in the immune system. By activating these receptors, O-2715 can influence various physiological responses.
Potential Applications[edit]
Research into O-2715 has focused on its potential therapeutic applications. As a cannabinoid receptor agonist, it may have potential uses in managing conditions such as chronic pain, inflammation, and neurological disorders. However, more research is needed to fully understand its efficacy and safety profile.
Safety and Toxicology[edit]
The safety profile of O-2715 is not fully established, and it is important to conduct thorough toxicological studies to determine any potential adverse effects. As with many synthetic compounds, there is a need for caution in its use until more comprehensive data is available.
Legal Status[edit]
The legal status of O-2715 varies by jurisdiction. In some regions, it may be classified as a controlled substance due to its potential psychoactive effects. Researchers must be aware of the legal regulations governing its use in their respective areas.
Also see[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian